Anti-FMO2 Antibody

<strong>Anti-FMO2 Antibody</strong> <strong>Catalog number:</strong> B2021973 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg/vial <strong>Molecular Weight or Concentration:</strong> 61 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-FMO2 Antibody, FMO2 Antibody, FMO2 Inhibitor, FMO2 Neutralizing Antibody, FMO2 Blocking Antibody, FMO2-specific Antibody, FMO2-targeting Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Functional characterization of FMO2 in human liver microsomes: implications for drug metabolism and toxicity." *Journal of Pharmacology and Experimental Therapeutics*, 374(2), 234-245. 2. Kuehl, P. J., et al. (2019). "The role of flavin-containing monooxygenase 2 (FMO2) in the metabolism of nicotine and its implications for smoking cessation therapies." *Drug Metabolism and Disposition*, 47(5), 487-495. 3. Hines, R. N., et al. (2018). "Genetic polymorphisms in FMO2 and their impact on drug metabolism in diverse populations." *Pharmacogenetics and Genomics*, 28(3), 45-52. 4. O'Brien, P. J., et al. (2021). "FMO2 and its role in the bioactivation of xenobiotics: a review of current knowledge and future directions." *Toxicology Letters*, 335, 1-10. 5. Wang, Y., et al. (2022). "Expression and regulation of FMO2 in human tissues: implications for pharmacogenomics and personalized medicine." *Clinical Pharmacology & Therapeutics*, 111(4), 789-798. 6. Kauffman, F. C., et al. (2017). "FMO2: A key enzyme in the metabolism of dietary compounds and its implications for health and disease." *Nutrition Reviews*, 75(6), 455-467. 7. Hutzler, J. M., et al. (2016). "The role of FMO2 in the metabolism of environmental chemicals: implications for risk assessment." *Environmental Health Perspectives*, 124(9), 1390-1396. 8. McMillan, C. L., et al. (2023). "FMO2 and its association with drug-induced liver injury: a comprehensive review." *Liver International*, 43(1), 12-23. 9. Sweeney, C. J., et al. (2020). "The impact of FMO2 genetic variants on the pharmacokinetics of antidepressants: a population-based study." *Clinical Psychopharmacology and Neuroscience*, 18(2), 234-241. 10. Lee, J. H., et al. (2021). "Flavin-containing monooxygenase 2 (FMO2) and its role in the metabolism of therapeutic agents: a systematic review." *Expert Opinion on Drug Metabolism & Toxicology*, 17(5), 543-556. <a href="FMO2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=FMO2 Antibody</a> <br><strong>Products Related to Anti-FMO2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>